Annual ROE
-32.98%
-12.53%-61.27%
December 31, 2023
Summary
- As of February 10, 2025, TXG annual return on equity is -32.98%, with the most recent change of -12.53% (-61.27%) on December 31, 2023.
- During the last 3 years, TXG annual ROE has risen by +60.66% (+64.78%).
- TXG annual ROE is now -164.50% below its all-time high of 51.13%, reached on December 31, 2018.
Performance
TXG ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-24.99%
+7.22%+22.42%
September 30, 2024
Summary
- As of February 10, 2025, TXG quarterly return on equity is -24.99%, with the most recent change of +7.22% (+22.42%) on September 30, 2024.
- Over the past year, TXG quarterly ROE has increased by +3.48% (+12.22%).
- TXG quarterly ROE is now -158.17% below its all-time high of 42.96%, reached on March 31, 2019.
Performance
TXG Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
TXG ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -61.3% | +12.2% |
| 3 y3 years | +64.8% | -234.1% |
| 5 y5 years | -164.5% | -27.3% |
TXG ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -340.9% | at low | -234.1% | +28.1% |
| 5 y | 5-year | -340.9% | +64.8% | -234.1% | +74.4% |
| alltime | all time | -164.5% | +64.8% | -158.2% | +81.9% |
10x Genomics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -24.99%(-22.4%) |
| Jun 2024 | - | -32.21%(-7.4%) |
| Mar 2024 | - | -34.77%(+6.0%) |
| Dec 2023 | -32.98%(+61.3%) | -32.81%(+15.2%) |
| Sep 2023 | - | -28.47%(+30.9%) |
| Jun 2023 | - | -21.75%(-0.8%) |
| Mar 2023 | - | -21.93%(+5.4%) |
| Dec 2022 | -20.45%(+173.4%) | -20.81%(-0.9%) |
| Sep 2022 | - | -20.99%(+17.7%) |
| Jun 2022 | - | -17.84%(+58.7%) |
| Mar 2022 | - | -11.24%(+50.3%) |
| Dec 2021 | -7.48% | -7.48%(-87.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | -58.36%(-19.1%) |
| Jun 2021 | - | -72.16%(-15.6%) |
| Mar 2021 | - | -85.52%(-12.2%) |
| Dec 2020 | -93.64%(+199.7%) | -97.45%(+258.0%) |
| Sep 2020 | - | -27.22%(+15.6%) |
| Jun 2020 | - | -23.55%(+1.0%) |
| Mar 2020 | - | -23.31%(+18.7%) |
| Dec 2019 | -31.24%(-161.1%) | -19.63%(-85.8%) |
| Sep 2019 | - | -137.91%(+3510.2%) |
| Jun 2019 | - | -3.82%(-108.9%) |
| Mar 2019 | - | 42.96%(+4.0%) |
| Dec 2018 | 51.13%(+206.5%) | 41.31% |
| Dec 2017 | 16.68% | - |
FAQ
- What is 10x Genomics annual return on equity?
- What is the all time high annual ROE for 10x Genomics?
- What is 10x Genomics annual ROE year-on-year change?
- What is 10x Genomics quarterly return on equity?
- What is the all time high quarterly ROE for 10x Genomics?
- What is 10x Genomics quarterly ROE year-on-year change?
What is 10x Genomics annual return on equity?
The current annual ROE of TXG is -32.98%
What is the all time high annual ROE for 10x Genomics?
10x Genomics all-time high annual return on equity is 51.13%
What is 10x Genomics annual ROE year-on-year change?
Over the past year, TXG annual return on equity has changed by -12.53% (-61.27%)
What is 10x Genomics quarterly return on equity?
The current quarterly ROE of TXG is -24.99%
What is the all time high quarterly ROE for 10x Genomics?
10x Genomics all-time high quarterly return on equity is 42.96%
What is 10x Genomics quarterly ROE year-on-year change?
Over the past year, TXG quarterly return on equity has changed by +3.48% (+12.22%)